SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Knighty Tin who wrote (8929)1/6/1997 9:24:00 PM
From: Knighty Tin   of 132070
 
To All, Interesting News and moves: 1. Genzyme Transgenics (gztc) will get $6 million from BASF over the next 3 years for some of the milk from its Frankenstein goats. If BASF's products are approved, GZTC also has the contract to be the commercial supplier. Good news as transgenics becomes more accepted. 2. Compaq cut prices 19 pct. on its notebooks for corporate customers. You know, the ones that are in such a shortage that they can't keep people supplied with them. -g- Do they think nobody notices what they are really doing while spreading those tall tales about shortages? Same trick they tried last year with the consumer pcs. "We are totally sold out" one day and "$100 rebate if you buy this same dogs" the next week. -g- They must eat licorice as a corporate requirement so nobody can notice their tongues turning black when they make their statements. 3. I did sell my last third of CPU puts, but it wasn't quite a triple after commish. Still, a nice trade on this bowwow. 4. I have sold my last third of Sangstat. Yes, I still love this co., but the price has gone waaaay beyond my semilog lines and for a silly reason, licensing somebody else's drug. This has been a major league winner for me in biotech and I hate to part co. with it, but it simply is not worth $34 IMHO. good luck, MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext